{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T11:14:33Z","timestamp":1760267673935},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Can J Public Health"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1007\/bf03404375","type":"journal-article","created":{"date-parts":[[2019,9,12]],"date-time":"2019-09-12T20:53:48Z","timestamp":1568321628000},"page":"210-212","source":"Crossref","is-referenced-by-count":11,"title":["Characteristics and Response to Treatment among Aboriginal People Receiving Heroin-assisted Treatment"],"prefix":"10.17269","volume":"101","author":[{"given":"Eugenia","family":"Oviedo-Joekes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daphne","family":"Guh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David C.","family":"Marsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne","family":"Brissette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bohdan","family":"Nosyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Krausz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aslam","family":"Anis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wayne M.","family":"Christian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Spittal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin T.","family":"Schechter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,5,1]]},"reference":[{"key":"BF03404375_CR1","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1097\/00126334-200210010-00015","volume":"31","author":"DR Gibson","year":"2002","unstructured":"Gibson DR, Brand R, Anderson K, Kahn JG, Perales D, Guydish J. Two- to sixfold decreased odds of HIV risk behavior associated with use of syringe exchange. J Acquir Immune Defic Syndr 2002;31:237\u201342.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"BF03404375_CR2","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1093\/aje\/kwi035","volume":"161","author":"F Termorshuizen","year":"2005","unstructured":"Termorshuizen F, Krol A, Prins M, van Ameijden EJ. Long-term outcome of chronic drug use: The Amsterdam Cohort Study among Drug Users. Am J Epidemiol 2005;161:271\u201379.","journal-title":"Am J Epidemiol"},{"key":"BF03404375_CR3","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1111\/j.1360-0443.2005.01089.x","volume":"100","author":"MT Brugal","year":"2005","unstructured":"Brugal MT, Domingo-Salvany A, Puig R, Barrio G, Garci\u00e1 de Olalla P, de la Fuente L. Evaluating the impact of methadone maintenance programmes on mortality due to overdose and AIDS in a cohort of heroin users in Spain. Addiction 2005;100:981\u201389.","journal-title":"Addiction"},{"key":"BF03404375_CR4","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1136\/bmj.327.7410.310","volume":"327","author":"W Brink van den","year":"2003","unstructured":"van den Brink W, Hendriks VM, Blanken P, Koeter MW, van Zwieten BJ, van Ree JM. Medical prescription of heroin to treatment resistant heroin addicts: Two randomised controlled trials. BMJ 2003;327:310.","journal-title":"BMJ"},{"key":"BF03404375_CR5","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/S0140-6736(01)06529-1","volume":"358","author":"J Rehm","year":"2001","unstructured":"Rehm J, Gschwend P, Steffen T, Gutzwiller F, Dobler-Mikola A, Uchtenhagen A. Feasibility, safety, and efficacy of injectable heroin prescription for refractory opioid addicts: A follow-up study. Lancet 2001;358:1417\u201323.","journal-title":"Lancet"},{"key":"BF03404375_CR6","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.jsat.2006.04.007","volume":"31","author":"JC March","year":"2006","unstructured":"March JC, Oviedo-Joekes E, Perea-Milla E, Carrasco F. Controlled trial of prescribed heroin in the treatment of opioid addiction. J Subst Abuse Treat 2006;31:203\u201311.","journal-title":"J Subst Abuse Treat"},{"key":"BF03404375_CR7","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1192\/bjp.bp.106.026112","volume":"191","author":"C Haasen","year":"2007","unstructured":"Haasen C, Verthein U, Degkwitz P, Berger J, Krausz M, Naber D. Heroinassisted treatment for opioid dependence: Randomised controlled trial. Br J Psychiatry 2007;191:55\u201362.","journal-title":"Br J Psychiatry"},{"key":"BF03404375_CR8","doi-asserted-by":"crossref","unstructured":"Oviedo-Joekes E, Brissette S, Marsh DC, Lauzon P, Guh D, Anis A, et al. Diacetylmorphine versus methadone for the treatment of opioid addiction. N Engl J Med 2009;361:777\u201386.","DOI":"10.1056\/NEJMoa0810635"},{"key":"BF03404375_CR9","volume-title":"HIV\/AIDS Epi Update.","author":"PHAC.","year":"2006","unstructured":"PHAC. HIV\/AIDS Among Aboriginal Peoples in Canada: A continuing concern. HIV\/AIDS Epi Update. Centre for Infectious Disease Prevention and Control, Public Health Agency of Canada, 2006."},{"key":"BF03404375_CR10","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.drugalcdep.2005.05.002","volume":"80","author":"T Kerr","year":"2005","unstructured":"Kerr T, Marsh D, Li K, Montaner J, Wood E. Factors associated with methadone maintenance therapy use among a cohort of polysubstance using injection drug users in Vancouver. Drug Alcohol Depend 2005;80:329\u201335.","journal-title":"Drug Alcohol Depend"},{"key":"BF03404375_CR11","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1177\/1740774509105222","volume":"6","author":"E Oviedo-Joekes","year":"2009","unstructured":"Oviedo-Joekes E, Nosyk B, Marsh D, Guh D, Brissette S, Gartry C, et al. Scientific and political challenges in North America\u2019s first randomized controlled trial of heroin-assisted treatment for severe heroin addiction: Rationale and design of the NAOMI Study. Clinical Trials 2009;6:261\u201371.","journal-title":"Clinical Trials"},{"key":"BF03404375_CR12","doi-asserted-by":"crossref","unstructured":"Oviedo-Joekes E, Nosyk B, Brissette S, Chettiar J, Schneeberger P, Marsh DC, et al. The North American Opiate Medication Initiative (NAOMI): Profile of Participants in North America\u2019s First Trial of Heroin-Assisted Treatment. J Urban Health 2008;85:812\u201325.","DOI":"10.1007\/s11524-008-9312-9"},{"key":"BF03404375_CR13","volume-title":"Best practices in methadone maintenance treatment","author":"Health Canada.","year":"2002","unstructured":"Health Canada. Best practices in methadone maintenance treatment. Ottawa, ON: Minister of Public Works and Government Services Canada, 2002."},{"key":"BF03404375_CR14","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1159\/000259089","volume":"1","author":"A Kokkevi","year":"1995","unstructured":"Kokkevi A, Hartgers C. EuropASI: European adaptation of a multidimensional assessment instrument for drug and alcohol dependence. Eur Addict Res 1995;1:208\u201310.","journal-title":"Eur Addict Res"},{"key":"BF03404375_CR15","doi-asserted-by":"crossref","unstructured":"Nosyk B, MacNab YC, Sun H, Fischer B, Marsh DC, Schechter MT, et al. Proportional hazards frailty models for recurrent methadone maintenance treatment. Am J Epidemiol 2009;170:783\u201392.","DOI":"10.1093\/aje\/kwp186"},{"key":"BF03404375_CR16","unstructured":"Craib KJ, Spittal PM, Wood E, Laliberte N, Hogg RS, Li K, et al. Risk factors for elevated HIV incidence among Aboriginal injection drug users in Vancouver. CMAJ 2003;168:19\u201324."},{"key":"BF03404375_CR17","volume-title":"Cochrane Database Syst Rev","author":"L Gowing","year":"2004","unstructured":"Gowing L, Farrell M, Bornemann R, Ali R. Substitution treatment of injecting opioid users for prevention of HIV infection. Cochrane Database Syst Rev 2004;CD004145."}],"container-title":["Canadian Journal of Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03404375.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03404375\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03404375.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T16:45:08Z","timestamp":1568393108000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03404375"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["BF03404375"],"URL":"https:\/\/doi.org\/10.1007\/bf03404375","relation":{},"ISSN":["0008-4263","1920-7476"],"issn-type":[{"value":"0008-4263","type":"print"},{"value":"1920-7476","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5]]}}}